» Articles » PMID: 29761104

Platelets in Immune Response to Virus and Immunopathology of Viral Infections

Overview
Specialty General Medicine
Date 2018 May 16
PMID 29761104
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Platelets are essential effector cells in hemostasis. Aside from their role in coagulation, platelets are now recognized as major inflammatory cells with key roles in the innate and adaptive arms of the immune system. Activated platelets have key thromboinflammatory functions linking coagulation to immune responses in various infections, including in response to virus. Recent studies have revealed that platelets exhibit several pattern recognition receptors (PRR) including those from the toll-like receptor, NOD-like receptor, and C-type lectin receptor family and are first-line sentinels in detecting and responding to pathogens in the vasculature. Here, we review the main mechanisms of platelets interaction with viruses, including their ability to sustain viral infection and replication, their expression of specialized PRR, and activation of thromboinflammatory responses against viruses. Finally, we discuss the role of platelet-derived mediators and platelet interaction with vascular and immune cells in protective and pathophysiologic responses to dengue, influenza, and human immunodeficiency virus 1 infections.

Citing Articles

Immunomodulation in dengue: towards deciphering dengue severity markers.

Dash M, Samal S, Rout S, Behera C, Sahu M, Das B Cell Commun Signal. 2024; 22(1):451.

PMID: 39327552 PMC: 11425918. DOI: 10.1186/s12964-024-01779-4.


Prediction of hospital-acquired influenza using machine learning algorithms: a comparative study.

Cho Y, Lee H, Kim J, Yoo K, Choi J, Lee Y BMC Infect Dis. 2024; 24(1):466.

PMID: 38698304 PMC: 11067145. DOI: 10.1186/s12879-024-09358-1.


The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study.

Fu H, Cai X, Cui L, Nong W, Li W, Mei H Ann Hematol. 2024; 103(5):1549-1559.

PMID: 38526649 DOI: 10.1007/s00277-024-05720-0.


Viruses and thrombocytopenia.

Rasizadeh R, Ebrahimi F, Kermanshahi A, Daei Sorkhabi A, Sarkesh A, Nahand J Heliyon. 2024; 10(6):e27844.

PMID: 38524607 PMC: 10957440. DOI: 10.1016/j.heliyon.2024.e27844.


Platelet index ratios in HIV: Emerging biomarkers for immune health and disease management.

Obeagu E, Obeagu G Medicine (Baltimore). 2024; 103(12):e37576.

PMID: 38518025 PMC: 10956946. DOI: 10.1097/MD.0000000000037576.


References
1.
Larsen E, Celi A, Gilbert G, Furie B, Erban J, Bonfanti R . PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989; 59(2):305-12. DOI: 10.1016/0092-8674(89)90292-4. View

2.
de Almeida A, Campos-de-Magalhaes M, Brandao-Mello C, de Oliveira R, do Espirito-Santo M, Yoshida C . Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome. Hepatogastroenterology. 2009; 56(90):429-36. View

3.
Marakalala M, Ndlovu H . Signaling C-type lectin receptors in antimycobacterial immunity. PLoS Pathog. 2017; 13(6):e1006333. PMC: 5481012. DOI: 10.1371/journal.ppat.1006333. View

4.
Zhou H, Qiu J, Wang T, Yu Y, Liu X, Li X . Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia. Blood. 2014; 124(22):3316-9. PMC: 4239337. DOI: 10.1182/blood-2014-06-580084. View

5.
Lazar R, Kersanske L, Xia Q, Daskalakis D, Braunstein S . Hospitalization Rates Among People With HIV/AIDS in New York City, 2013. Clin Infect Dis. 2017; 65(3):469-476. DOI: 10.1093/cid/cix343. View